文献速递临床免疫

双抗原结合SARS-CoV-2血清学检测抗体动力学与其他方法存在差异

SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods.
PubMed 文献 · J Clin Microbiol · 2021-08-18

该纵向研究对44名康复期血浆捐献者症状发作后120天内的血清用8种方法连续检测SARS-CoV-2抗体。多数方法抗体滴度逐渐下降,但两种采用双抗原结合的罗氏电化学发光法检测显示抗体滴度稳定或上升,提示抗体检测结果依赖所用血清学方法。

要点

  • 多数SARS-CoV-2血清学方法在120天内抗体滴度逐渐下降。
  • 双抗原结合的罗氏电化学发光法显示抗体滴度稳定或上升。
  • 抗体检测结果依赖所用血清学方法,影响临床应用。

核心结论

  • SARS-CoV-2抗体检测结果取决于所用血清学方法,双抗原结合检测的动力学与其他方法不同。

研究设计与样本

  • 纵向研究,纳入44名特征明确的康复期血浆捐献者,症状发作后120天内连续检测血清。
  • 使用8种血清学方法,抗原来源、检测抗体同种型和测量活性(结合、阻断或中和)不同。

主要发现

  • 多数方法在120天内抗体滴度逐渐下降。
  • 两种罗氏电化学发光法(Elecsys anti-SARS-CoV-2定性核衣壳法、Elecsys anti-SARS-CoV-2 S半定量刺突法)采用双抗原结合,显示抗体滴度稳定和/或上升。

临床怎么用

  • 选择SARS-CoV-2血清学方法时应考虑检测原理对结果的影响。

局限性

  • 样本量44例,随访120天。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Longitudinal studies assessing durability of the anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) humoral immune response have generated conflicting results. This has been proposed to be due to differences in patient populations, the lack of standardized methodologies, and the use of assays that measure distinct aspects of the humoral response. SARS-CoV-2 antibodies were serially measured in sera from a cohort of 44 well-characterized convalescent plasma donors over 120 days post-COVID-19 symptom onset, utilizing eight assays, which varied according to antigen source, the detected antibody isotype, and the activity measured (i.e., binding, blocking, or neutralizing). While the majority of assays demonstrated a gradual decline in antibody titers over the course of 120 days, the two electrochemiluminescence immunoassay Roche assays (Roche Diagnostics Elecsys anti-SARS-CoV-2 [qualitative, nucleocapsid based] and Roche Diagnostics Elecsys anti-SARS-CoV-2 S [semiquantitative, spike based]), which utilize dual-antigen binding for antibody detection, demonstrated stable and/or increasing antibody titers over the study period. This study is among the first to assess longitudinal, rather than cross-sectional, SARS-CoV-2 antibody profiles among convalescent COVID-19 patients, primarily using commercially available serologic assays with Food and Drug Administration emergency use authorization. We show that SARS-CoV-2 antibody detection is dependent on the serologic method used, which has implications for future assay utilization and clinical value.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Theel ES, Johnson PW, Kunze KL, et al. SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods. J Clin Microbiol. 2021. PMID: 34166066. doi:10.1128/JCM.01231-21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。